NCT04303403 2023-10-11
Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
National Cancer Centre, Singapore
Phase 1 Unknown
Clinical Trials
10 trialsNCT05413356 2022-10-19
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT05566535 2022-10-04
QoL-PV-R
Multinational Center for Quality of Life Research, Russia
Unknown
NCT05039580 2021-09-09
SEHC
The First Affiliated Hospital of Soochow University
Phase 4 Unknown
NCT04582604 2020-10-20
Ruxolitinib and Decitabine for High Risk Hematological Malignancies
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT03669965 2020-07-31
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Kartos Therapeutics, Inc.
Phase 2 Unknown
NCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT03558607 2020-03-19
The Role of Ruxolitinib in Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Neoplasm
Seoul National University Hospital
Phase 1/2 Unknown
NCT03613428 2018-08-03
Ruxolitinib Plus LVP in Patients With R/R ETP-ALL
Sichuan University
Phase 1/2 Unknown
NCT02912754 2017-03-13
Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown